280 related articles for article (PubMed ID: 24577091)
1. An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity.
Krause U; Ryan DM; Clough BH; Gregory CA
Cell Death Dis; 2014 Feb; 5(2):e1093. PubMed ID: 24577091
[TBL] [Abstract][Full Text] [Related]
2. Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.
Thudi NK; Martin CK; Murahari S; Shu ST; Lanigan LG; Werbeck JL; Keller ET; McCauley LK; Pinzone JJ; Rosol TJ
Prostate; 2011 May; 71(6):615-25. PubMed ID: 20957670
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional in vitro modeling of malignant bone disease recapitulates experimentally accessible mechanisms of osteoinhibition.
McNeill EP; Reese RW; Tondon A; Clough BH; Pan S; Froese J; Palmer D; Krause U; Loeb DM; Kaunas R; Gregory CA
Cell Death Dis; 2018 Nov; 9(12):1161. PubMed ID: 30478297
[TBL] [Abstract][Full Text] [Related]
4. Effects of Dickkopf-1 (DKK-1) on Prostate Cancer Growth and Bone Metastasis.
Yuan S; Hoggard NK; Kantake N; Hildreth BE; Rosol TJ
Cells; 2023 Nov; 12(23):. PubMed ID: 38067123
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
Fromigué O; Hamidouche Z; Marie PJ
J Biol Chem; 2008 Nov; 283(45):30549-56. PubMed ID: 18757369
[TBL] [Abstract][Full Text] [Related]
6. A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies.
Lee N; Smolarz AJ; Olson S; David O; Reiser J; Kutner R; Daw NC; Prockop DJ; Horwitz EM; Gregory CA
Br J Cancer; 2007 Dec; 97(11):1552-9. PubMed ID: 17987039
[TBL] [Abstract][Full Text] [Related]
7. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
[TBL] [Abstract][Full Text] [Related]
8. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
9. p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1.
Hall CL; Zhang H; Baile S; Ljungman M; Kuhstoss S; Keller ET
Cancer Res; 2010 Dec; 70(23):9916-26. PubMed ID: 21098705
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model.
Goldstein SD; Trucco M; Bautista Guzman W; Hayashi M; Loeb DM
Oncotarget; 2016 Apr; 7(16):21114-23. PubMed ID: 27049730
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.
Rachner TD; Göbel A; Thiele S; Rauner M; Benad-Mehner P; Hadji P; Bauer T; Muders MH; Baretton GB; Jakob F; Ebert R; Bornhäuser M; Schem C; Hofbauer LC
Breast Cancer Res; 2014 Feb; 16(1):R20. PubMed ID: 24528599
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
13. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells.
Mikheev AM; Mikheeva SA; Maxwell JP; Rivo JV; Rostomily R; Swisshelm K; Zarbl H
Breast Cancer Res Treat; 2008 Nov; 112(2):263-73. PubMed ID: 18157634
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.
Giralt I; Gallo-Oller G; Navarro N; Zarzosa P; Pons G; Magdaleno A; Segura MF; Sábado C; Hladun R; Arango D; Sánchez de Toledo J; Moreno L; Gallego S; Roma J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884726
[TBL] [Abstract][Full Text] [Related]
15. Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanisms.
Pan S; Cesarek M; Godoy C; Co CM; Schindler C; Padilla K; Haskell A; Barreda H; Story C; Poole R; Dabney A; Gregory CA
Br J Cancer; 2022 Jul; 127(1):43-55. PubMed ID: 35277659
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.
Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET
Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis.
Xia P; Gu R; Zhang W; Shao L; Li F; Wu C; Sun Y
J Cell Physiol; 2019 Dec; 234(12):22787-22798. PubMed ID: 31152456
[TBL] [Abstract][Full Text] [Related]
18. P38 regulates the Wnt inhibitor Dickkopf-1 in breast cancer.
Rachner TD; Göbel A; Browne A; Hötzel J; Rauner M; Hofbauer LC
Biochem Biophys Res Commun; 2015 Oct; 466(4):728-32. PubMed ID: 26407843
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro.
Zou YC; Yang XW; Yuan SG; Zhang P; Ye YL; Li YK
Connect Tissue Res; 2016 May; 57(3):200-11. PubMed ID: 26837533
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways.
Liang CZ; Zhang X; Li H; Tao YQ; Tao LJ; Yang ZR; Zhou XP; Shi ZL; Tao HM
Cancer Biother Radiopharm; 2012 Dec; 27(10):701-10. PubMed ID: 22849560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
